Stock Track | MannKind Soars 6.03% After-Hours on Strong Q4 Earnings Beat

Stock Track

02-27

MannKind Corporation (MNKD) shares surged 6.03% in after-hours trading on Wednesday, following the release of the company's better-than-expected fourth-quarter financial results.

The biopharmaceutical company reported an operating income of $26.495 million for the quarter ended December 31, 2024, compared to an operating loss in the year-ago period. Net income came in at $7.422 million, or $0.03 per basic share, significantly outperforming analysts' estimates.

The strong quarterly performance likely fueled investor optimism, driving MannKind's stock higher in extended trading hours. However, more details on the company's revenue, pipeline updates, and forward guidance will be needed to assess the sustainability of the after-hours rally.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1188875274"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1188875274\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/1188875274?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-27 05:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1188875274","market":"hk","top_or_hot":-1,"title":"Stock Track | MannKind Soars 6.03% After-Hours on Strong Q4 Earnings Beat","media":"Stock Track","content":"<html><body><p>MannKind Corporation (MNKD) shares surged 6.03% in after-hours trading on Wednesday, following the release of the company's better-than-expected fourth-quarter financial results.</p>\n<p>The biopharmaceutical company reported an operating income of $26.495 million for the quarter ended December 31, 2024, compared to an operating loss in the year-ago period. Net income came in at $7.422 million, or $0.03 per basic share, significantly outperforming analysts' estimates.</p>\n<p>The strong quarterly performance likely fueled investor optimism, driving MannKind's stock higher in extended trading hours. However, more details on the company's revenue, pipeline updates, and forward guidance will be needed to assess the sustainability of the after-hours rally.</p></body></html>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>Stock Track | MannKind Soars 6.03% After-Hours on Strong Q4 Earnings Beat</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | MannKind Soars 6.03% After-Hours on Strong Q4 Earnings Beat\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-27 05:46</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>MannKind Corporation (MNKD) shares surged 6.03% in after-hours trading on Wednesday, following the release of the company's better-than-expected fourth-quarter financial results.</p>\n<p>The biopharmaceutical company reported an operating income of $26.495 million for the quarter ended December 31, 2024, compared to an operating loss in the year-ago period. Net income came in at $7.422 million, or $0.03 per basic share, significantly outperforming analysts' estimates.</p>\n<p>The strong quarterly performance likely fueled investor optimism, driving MannKind's stock higher in extended trading hours. However, more details on the company's revenue, pipeline updates, and forward guidance will be needed to assess the sustainability of the after-hours rally.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MNKD","symbol_name":"曼恩凯德生物医疗","start_time":0,"source_url":"","article_id":"1188875274","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1188875274","pubTimestamp":1740606394,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"MannKind Corporation  shares surged 6.03% in after-hours trading on Wednesday, following the release of the company's better-than-expected fourth-quarter financial results.The biopharmaceutical company reported an operating income of $26.495 million for the quarter ended December 31, 2024, compared to an operating loss in the year-ago period. Net income came in at $7.422 million, or $0.03 per basic share, significantly outperforming analysts' estimates.The strong quarterly performance likely fue","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MNKD":"曼恩凯德生物医疗"},"translate_title":"股票赛道MannKind因第四季度盈利强劲而盘后飙升6.03%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MNKD":1},"content_text":"MannKind Corporation (MNKD) shares surged 6.03% in after-hours trading on Wednesday, following the release of the company's better-than-expected fourth-quarter financial results.\nThe biopharmaceutical company reported an operating income of $26.495 million for the quarter ended December 31, 2024, compared to an operating loss in the year-ago period. Net income came in at $7.422 million, or $0.03 per basic share, significantly outperforming analysts' estimates.\nThe strong quarterly performance likely fueled investor optimism, driving MannKind's stock higher in extended trading hours. However, more details on the company's revenue, pipeline updates, and forward guidance will be needed to assess the sustainability of the after-hours rally.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1}}}